Clinical Trials in Minneapolis

Showing 9601-9620 of 12,418 trials

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

NCT00403637

The study is designed to obtain safety and efficacy data on three dose levels of indacaterol when delivered via an SDDPI in patients with persistent asthma. All patients will receive 1 day of treatment with each of the following: indacaterol 150 µg, indacaterol 300 µg, indacaterol 600 µg, placebo, and formoterol. Each treatment day will be followed by a washout-period of 1 week

Asthma

Novartis45 participantsStarted Nov 2006

Denver, Colorado, United States • North Dartmouth, Massachusetts, United States • Minneapolis, Minnesota, United States +2 more locations

COMPLETEDPhase 1< 1 mile

PK Study of Sotagliflozin in Subjects With Hepatic Impairment

NCT02471274

To evaluate the effect of mild, moderate, or severe hepatic impairment on the pharmacokinetics (PK) of a single dose of 400 mg sotagliflozin (2 x 200-mg tablets) compared with healthy, demographically-matched subjects.

Hepatic ImpairmentHealthy

Lexicon Pharmaceuticals32 participantsStarted Jun 2015

Lakewood, Colorado, United States • Miami, Florida, United States • Orlando, Florida, United States +1 more locations

WITHDRAWNPhase 4< 1 mile

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

NCT01372670

The purpose of this study is to determine the effectiveness of hydroxyzine in the treatment of meal-related anxiety in adolescents and young adults 8 to 25 years of age diagnosed with an eating disorder who are underweight. The investigators want to find out if hydroxyzine given before meals will improve meal-related anxiety compared to no hydroxyzine.

Anxiety in Those Patients With Anorexia NervosaEating Disorder Not Otherwise Specified, BMI (<=18)

HealthPartners InstituteStarted Jan 2012

Minneapolis, Minnesota, United States

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

PK Study of Sotagliflozin in Subjects With Hepatic Impairment

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

Find Trials by Condition in Minneapolis

Noninvasive Evaluation of Cardiac Allograft Vasculopathy

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Clinical Study of Approved and Investigational Contact Lenses

Perceval S Aortic Heart Valve Study- North America

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Trial of Educational Outcomes of WISE-MD

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease

Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

A Study of HIV in Newly Infected Individuals

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Observational Study of Golimumab Intravenous Infusion

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer